Pharmasset, Inc. · Princeton, NJ United States
Key Pharmasset, Inc. Financials
| Company Type | Public -
|
|---|
| Fiscal Year-End | September |
|---|
| 2011 Sales (mil.) | $0.9 |
|---|
| 2011 Employees | 82 |
|---|
For a Hoover's Free Trial, Call
(866) 444-8642
or
Chat Now
Pharmasset, Inc. Income Statement
| Sep 11 | Sep 10 | Sep 09 |
| Revenue | 0.9 | 1.0 | 13.3 |
| Cost of Goods Sold | 0.0 | 0.0 | 0.0 |
| Gross Profit | 0.9 | 1.0 | 13.3 |
| Gross Profit Margin | 100% | 100% | 100% |
| SG&A Expense | 16.7 | 16.5 | 13.4 |
| Depreciation & Amortization | 0.6 | 0.9 | 1.0 |
| Operating Income | (91.6) | (63.7) | (52.6) |
| Operating Margin | -10212.3% | -6245% | -395.9% |
| Nonoperating Income | 0.5 | 0.0 | 0.2 |
| Nonoperating Expenses | (1.1) | (2.4) | (3.2) |
| Income Before Taxes | (92.2) | (66.1) | (55.6) |
| Income Taxes | (1.0) | | |
| Net Income After Taxes | (91.2) | (66.1) | (55.6) |
| Continuing Operations | (91.2) | (66.1) | (55.6) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (91.2) | (66.1) | (55.6) |
| Total Net Income | (91.2) | (66.1) | (55.6) |
| Net Profit Margin | -10165.6% | -6478.6% | -418.2% |
| Diluted EPS from Total Net Income | (1.25) | (1.07) | (0.53) |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Pharmasset, Inc. Balance Sheet
| Assets | Sep 11 | Sep 10 | Sep 09 |
| Current Assets |
| Cash | 166.5 | 127.1 | 58.4 |
| Net Receivables | 0.0 | 0.0 | 0.4 |
| Inventories | -- | -- | -- |
| Other Current Assets | 3.5 | 0.7 | 1.7 |
| Total Current Assets | 170.0 | 127.8 | 60.4 |
| Net Fixed Assets | 2.0 | 1.7 | 2.0 |
| Other Noncurrent Assets | 0.2 | 0.2 | 0.3 |
| Total Assets | 172.2 | 129.8 | 62.7 |
| Liabilities | Sep 11 | Sep 10 | Sep 09 |
| Current Liabilities |
| Accounts Payable | 5.7 | 5.0 | 2.5 |
| Short-Term Debt | 2.5 | 8.7 | 7.5 |
| Other Current Liabilities | 8.1 | 6.9 | 8.7 |
| Total Current Liabilities | 16.3 | 20.6 | 18.8 |
| Long-Term Debt | 0.1 | 2.9 | 12.1 |
| Other Noncurrent Liabilities | 1.5 | 2.1 | 3.0 |
| Total Liabilities | 17.9 | 25.6 | 33.8 |
| Shareholder's Equity |
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 154.3 | 104.1 | 28.9 |
| Total Equity | 154.3 | 104.1 | 28.9 |
| Shares Outstanding (thou.) | 75,556.0 | 68,087.8 | 56,536.0 |
All amounts in millions of US Dollars except per share amounts.
Pharmasset, Inc. Cash Flow Statement
| Sep 11 | Sep 10 | Sep 09 |
| Net Operating Cash Flow | (84) | (58) | (50) |
| Net Investing Cash Flow | (0.9) | (0.5) | 0.1 |
| Net Financing Cash Flow | 124.3 | 127.5 | 44.7 |
| Net Change in Cash | 39.4 | 68.7 | (4.7) |
| Depreciation & Amortization | 0.6 | 0.9 | 1.0 |
| Capital Expenditures | (0.9) | (0.5) | (0.3) |
| Cash Dividends Paid | | | |
All amounts in millions of US Dollars except per share amounts.
